Bellevue Funds (Lux) - Bellevue AI Health Bellevue Funds (Lux) - Bellevue AI Health I2

Reference Data

ISIN LU2721086507
Valor Number
Bloomberg Global ID
Fund Name Bellevue Funds (Lux) - Bellevue AI Health Bellevue Funds (Lux) - Bellevue AI Health I2
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Sub-fund is an actively managed equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of Bellevue AI Health in a portfolio of carefully chosen shares and preference shares of companies whose business activities have a strong focus on the provision and/or use of artificial intelligence (AI) in the health sector or whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries.
Peculiarities

Fund Prices

Current Price * 137.35 USD 02.04.2025
Previous Price * 137.04 USD 01.04.2025
52 Week High * 155.40 USD 30.08.2024
52 Week Low * 131.90 USD 18.04.2024
NAV * 137.35 USD 02.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 11,160,367
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance +3.11% 31.12.2024
02.04.2025
YTD Performance (in CHF) +0.17% 31.12.2024
02.04.2025
1 month -4.29% 03.03.2025
02.04.2025
3 months +2.99% 02.01.2025
02.04.2025
6 months -7.99% 02.10.2024
02.04.2025
1 year +0.31% 02.04.2024
02.04.2025
2 years +3.81% 24.01.2024
02.04.2025
3 years - -
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 10.13%
UnitedHealth Group Inc 6.86%
Johnson & Johnson 4.68%
AbbVie Inc 4.67%
Roche Holding AG 3.65%
Novo Nordisk AS Class B 3.63%
Merck & Co Inc 3.38%
Abbott Laboratories 3.34%
AstraZeneca PLC 3.21%
Intuitive Surgical Inc 3.21%
Last data update 28.02.2025

Cost / Risk

TER *** 1.37%
TER date *** 31.12.2024
Performance Fee ***
PTR
Max. Management Fee *** 0.80%
Ongoing Charges *** 1.37%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)